Spectrascience New Net Worth
Spectrascience New Net Worth Breakdown | SCIE |
Spectrascience New Net Worth Analysis
Spectrascience New's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Spectrascience New's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Spectrascience New's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Spectrascience New's net worth analysis. One common approach is to calculate Spectrascience New's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Spectrascience New's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Spectrascience New's net worth. This approach calculates the present value of Spectrascience New's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Spectrascience New's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Spectrascience New's net worth. This involves comparing Spectrascience New's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Spectrascience New's net worth relative to its peers.
To determine if Spectrascience New is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Spectrascience New's net worth research are outlined below:
Spectrascience New generated a negative expected return over the last 90 days | |
Spectrascience New has some characteristics of a very speculative penny stock | |
Spectrascience New has high likelihood to experience some financial distress in the next 2 years | |
Spectrascience New currently holds 6.38 M in liabilities. Spectrascience New has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Spectrascience New's use of debt, we should always consider it together with its cash and equity. | |
The entity reported the previous year's revenue of 5.15 K. Net Loss for the year was (4.47 M) with loss before overhead, payroll, taxes, and interest of (196.44 K). | |
Spectrascience New currently holds about 27.88 K in cash with (1.51 M) of positive cash flow from operations. | |
Spectrascience New has a frail financial position based on the latest SEC disclosures |
Follow Spectrascience New's market capitalization trends
The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.92 K.Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Spectrascience New insiders, such as employees or executives, is commonly permitted as long as it does not rely on Spectrascience New's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Spectrascience New insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Miller Sheldon L over three months ago Acquisition by Miller Sheldon L of 100000 shares of Spectrascience New at 0.06 subject to Rule 16b-3 |
Spectrascience New Earnings per Share Projection vs Actual
Spectrascience New Corporate Executives
Elected by the shareholders, the Spectrascience New's board of directors comprises two types of representatives: Spectrascience New inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Spectrascience. The board's role is to monitor Spectrascience New's management team and ensure that shareholders' interests are well served. Spectrascience New's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Spectrascience New's outside directors are responsible for providing unbiased perspectives on the board's policies.
Lowell Giffhorn | CFO, Principal Accounting Officer and Secretary | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Spectrascience New. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For information on how to trade Spectrascience Stock refer to our How to Trade Spectrascience Stock guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Spectrascience New. If investors know Spectrascience will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Spectrascience New listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Spectrascience New is measured differently than its book value, which is the value of Spectrascience that is recorded on the company's balance sheet. Investors also form their own opinion of Spectrascience New's value that differs from its market value or its book value, called intrinsic value, which is Spectrascience New's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Spectrascience New's market value can be influenced by many factors that don't directly affect Spectrascience New's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Spectrascience New's value and its price as these two are different measures arrived at by different means. Investors typically determine if Spectrascience New is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Spectrascience New's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.